Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129015) titled 'A Retrospective Cohort Study on the Association Between Liposomal Doxorubicin and Risk of Infectious Pneumonia in Breast Cancer Patients' on July 29.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Fifth Affiliated hospital of Sun Yet-sen University
Condition:
Breast cancer
Pneumonia
Intervention:
Liposomal doxorubicin group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-30
Target Sample Size: Liposomal doxorubicin group:226;Epirubicin group:148;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...